Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females

Development of a novel diagnostic model to monitor the progression of metabolic dysfunction-associated steatotic liver disease to hepatocellular carcinoma in females

Abstract Background and aims The onset of metabolic dysfunction-associated steatotic liver disease-associated hepatocellular carcinoma (MASLD-HCC) is insidious and exhibits sex-specific variations. Effective methods for monitoring MASLD-HCC progression in females have not yet been developed. Methods...

Full description

Bibliographic Details
Main Authors: Xiaoning Gan, Yun Zhou, Yonghao Li, Lin Xu, Guolong Liu
Format: Article
Language:English
Published: Springer 2024-12-01
Series:Discover Oncology
Subjects:
Metabolic dysfunction-associated steatotic liver disease (MASLD)
Metabolic-associated steatohepatitis (MASH)
Hepatocellular carcinoma (HCC)
Differentially expressed genes
Diagnostic prediction model
Female sex-specific variations
Online Access:https://doi.org/10.1007/s12672-024-01636-3

Internet

https://doi.org/10.1007/s12672-024-01636-3

Similar Items